Published in J Hepatol on January 15, 2013
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology (2014) 2.00
Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol (2013) 1.49
Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. Am J Gastroenterol (2016) 0.99
Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To. PLoS One (2014) 0.78
Assessment of liver fibrosis in chronic hepatitis B using acoustic structure quantification: quantitative morphological ultrasound. Eur Radiol (2015) 0.78
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. Oncotarget (2016) 0.77
Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study. Hepat Mon (2013) 0.77
Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2015) 0.76
Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. World J Gastroenterol (2015) 0.76
Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy. Int J Pediatr (2016) 0.75
Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators. World J Gastroenterol (2016) 0.75
Value of liver elastography and abdominal ultrasound for detection of complications of allogeneic hemopoietic SCT. Bone Marrow Transplant (2014) 0.75
Simultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesions. Sci Rep (2016) 0.75
Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients. PLoS One (2015) 0.75
Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C. Clin Interv Aging (2016) 0.75
Ultrasound imaging of the liver and bile ducts - expectations of a clinician. J Ultrason (2015) 0.75
Acoustic structure quantification by using ultrasound Nakagami imaging for assessing liver fibrosis. Sci Rep (2016) 0.75
Effect of ultrasound frequency on the Nakagami statistics of human liver tissues. PLoS One (2017) 0.75
Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology (2006) 3.19
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology (2009) 2.45
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol (2005) 1.94
Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology (2004) 1.92
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem (2007) 1.84
Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum Mutat (2008) 1.78
Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology (2009) 1.55
Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol (2007) 1.49
Hepatitis B vaccination in HIV-infected patients: a survey of physicians and patients participating in the Aquitaine cohort. Gastroenterol Clin Biol (2006) 1.42
Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J Clin Psychiatry (2005) 1.41
[Steasis and hepatitis C]. Gastroenterol Clin Biol (2003) 1.41
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2010) 1.41
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol (2006) 1.25
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 1.17
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol (2011) 1.12
Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. J Hepatol (2010) 1.01
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol (2008) 0.94
The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis (2004) 0.92
Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol (2014) 0.92
FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology (2006) 0.88
Psychosocial factors associated with perceived disease severity in patients with chronic hepatitis C: relationship with information sources and attentional coping styles. Psychosomatics (2005) 0.88
Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines. J Leukoc Biol (2007) 0.86
Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat (2010) 0.86
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation. Antivir Ther (2009) 0.83
[Hepatitis C virus screening in drug users in an addiction out-patient unit]. Gastroenterol Clin Biol (2002) 0.80
Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Res (2011) 0.79
Assessing liver disease in HIV-HCV coinfected patients. Curr Opin HIV AIDS (2015) 0.78
Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography. Eur Radiol (2014) 0.78
Liver stiffness and hepatocellular carcinoma: liaisons dangereuses? Hepatology (2009) 0.78
HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system. Gastroenterol Clin Biol (2007) 0.77
A missense variant within BRCA1 exon 23 causing exon skipping. Cancer Genet Cytogenet (2010) 0.77
Biomarkers in liver disease: emerging methods and potential applications. Int J Hepatol (2012) 0.75
Acoustic radiation force impulse imaging: a new technology for the noninvasive assessment of liver fibrosis? J Gastrointestin Liver Dis (2009) 0.75
Diagnosing cirrhosis non-invasively: sense the stiffness but don't forget the nodules! J Hepatol (2010) 0.75
[Managing comorbidities in hepatology: toward a more holistic medicine]. Presse Med (2008) 0.75
[Brief intervention about alcohol use]. Presse Med (2009) 0.75
[Liver biopsy in management of chronic liver diseases: "EASL monothematic conference highlights"]. Gastroenterol Clin Biol (2006) 0.75
Intratumoral gas in hepatocellular carcinoma following transarterial chemoembolization: associated factors and clinical impact. J Vasc Interv Radiol (2013) 0.75